NO985791L - Device for transdermal administration of trimegestone, method of preparation of the device and its use as a drug - Google Patents

Device for transdermal administration of trimegestone, method of preparation of the device and its use as a drug

Info

Publication number
NO985791L
NO985791L NO985791A NO985791A NO985791L NO 985791 L NO985791 L NO 985791L NO 985791 A NO985791 A NO 985791A NO 985791 A NO985791 A NO 985791A NO 985791 L NO985791 L NO 985791L
Authority
NO
Norway
Prior art keywords
trimegestone
drug
preparation
transdermal administration
transdermal
Prior art date
Application number
NO985791A
Other languages
Norwegian (no)
Other versions
NO315149B1 (en
NO985791D0 (en
Inventor
Jean-Luc Dubois
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO985791D0 publication Critical patent/NO985791D0/en
Publication of NO985791L publication Critical patent/NO985791L/en
Publication of NO315149B1 publication Critical patent/NO315149B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19985791A 1996-06-11 1998-12-10 Adhesive polymer matrix applied to a device for transdermal administration of a progestomimetic compound, device for transdermal administration of a progestomimetric compound, and method of preparing the device NO315149B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607208A FR2749586B1 (en) 1996-06-11 1996-06-11 NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS
PCT/FR1997/001023 WO1997047333A1 (en) 1996-06-11 1997-06-10 Novel devices for transdermal administering of trimegestone

Publications (3)

Publication Number Publication Date
NO985791D0 NO985791D0 (en) 1998-12-10
NO985791L true NO985791L (en) 1999-02-11
NO315149B1 NO315149B1 (en) 2003-07-21

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985791A NO315149B1 (en) 1996-06-11 1998-12-10 Adhesive polymer matrix applied to a device for transdermal administration of a progestomimetic compound, device for transdermal administration of a progestomimetric compound, and method of preparing the device

Country Status (23)

Country Link
EP (1) EP0906127B1 (en)
JP (1) JP2000514416A (en)
CN (1) CN1110327C (en)
AR (1) AR013580A1 (en)
AT (1) ATE216269T1 (en)
AU (1) AU717335B2 (en)
BR (1) BR9709690A (en)
CA (1) CA2257902A1 (en)
CZ (1) CZ295227B6 (en)
DE (1) DE69712057T2 (en)
DK (1) DK0906127T3 (en)
ES (1) ES2173453T3 (en)
FR (1) FR2749586B1 (en)
HU (1) HU225034B1 (en)
IL (1) IL127281A0 (en)
NO (1) NO315149B1 (en)
PL (1) PL189533B1 (en)
PT (1) PT906127E (en)
RU (1) RU2204417C2 (en)
TR (1) TR199802578T2 (en)
TW (1) TW474826B (en)
WO (1) WO1997047333A1 (en)
ZA (1) ZA975168B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (en) * 1998-08-27 2001-09-14 Oreal AEROSOL DEVICE CONTAINING A POLYCONDENSATE COMPRISING AT LEAST ONE POLYURETHANE AND / OR POLYUREA PATTERN
ITMI20020798A1 (en) * 2002-04-15 2003-10-15 F T Holding S A SILICONE ADHESIVE MATERIAL TRANSDERMAL PATCHES STABILIZED WITH METHACRYLIC COPOLYMERS
UA84303C2 (en) * 2003-10-28 2008-10-10 Новен Фармасьютикалз, Инк. Transdermal drug delivery system
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch
JP2006230930A (en) * 2005-02-28 2006-09-07 Alcare Co Ltd Pasting material
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (en) * 1978-07-13 1980-02-08 Roussel Uclaf NOVEL 3,20-DIOXO 4,9-DIENE 21-HYDROXYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel

Also Published As

Publication number Publication date
ES2173453T3 (en) 2002-10-16
AU717335B2 (en) 2000-03-23
NO315149B1 (en) 2003-07-21
WO1997047333A1 (en) 1997-12-18
HUP9903340A3 (en) 2000-04-28
RU2204417C2 (en) 2003-05-20
FR2749586A1 (en) 1997-12-12
CN1227503A (en) 1999-09-01
ATE216269T1 (en) 2002-05-15
ZA975168B (en) 1998-07-22
AU3266097A (en) 1998-01-07
IL127281A0 (en) 1999-09-22
PL330535A1 (en) 1999-05-24
FR2749586B1 (en) 1998-08-07
CA2257902A1 (en) 1997-12-18
PL189533B1 (en) 2005-08-31
CZ295227B6 (en) 2005-06-15
JP2000514416A (en) 2000-10-31
CZ410798A3 (en) 1999-09-15
DE69712057T2 (en) 2002-10-02
BR9709690A (en) 1999-08-10
NO985791D0 (en) 1998-12-10
TW474826B (en) 2002-02-01
DK0906127T3 (en) 2002-08-05
AR013580A1 (en) 2001-01-10
TR199802578T2 (en) 1999-03-22
CN1110327C (en) 2003-06-04
EP0906127B1 (en) 2002-04-17
HUP9903340A2 (en) 2000-03-28
EP0906127A1 (en) 1999-04-07
HU225034B1 (en) 2006-05-29
DE69712057D1 (en) 2002-05-23
PT906127E (en) 2002-09-30

Similar Documents

Publication Publication Date Title
NO991815D0 (en) Oxadiazoles, processes for their preparation and their use as drugs
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
DK0966454T3 (en) Disubstituted bicyclic heterocycles, their preparation and their use as drugs
DK0797991T3 (en) Delayed-release drug formulation
EE9700241A (en) Pharmaceutical composition for transdermal administration
AU2109195A (en) Two-component device for the administration of drugs
DK0826673T3 (en) Acetamide derivatives, processes for their preparation and medical preparations
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
ITMI961152A0 (en) THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF
ITRM910922A0 (en) ANTIPHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE FOR PREPARING IT AND METHOD FOR APPLYING IT.
ITRM920412A1 (en) HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE.
DK0771788T3 (en) Substituted sulfonimidamides, processes for their preparation, use thereof as a drug or diagnostic agent, and
DK0868911T3 (en) Rapamycin preparations for oral administration
NO985791D0 (en) Device for transdermal administration of trimegestone, method of preparation of the device and its use as a drug
AU3170697A (en) Transdermal drug delivery device for the delivery of tropisetron or granisetron
EE9400296A (en) Piperidinylthioindole derivatives, dosage forms, active analgesic, methods for their preparation
NO940130D0 (en) Benzimidazole derivatives, methods for their preparation and the therapeutic use thereof
NO863460D0 (en) PROCEDURE FOR THE PREPARATION OF 6-PHENOXYMETHYL-4-HYDROXY-TETRAHYDROPYRAN-2-ON, PROCEDURE FOR THEIR PREPARATION, AND THEIR USE AS MEDICINE, PHARMACEUTICAL AND PREPARATORY PREPARATORY PREPARES.
DK0879054T3 (en) Use of pyrrolidione derivatives for the manufacture of drugs for the treatment of drug addiction
NO890096D0 (en) PYRAZOL AND INDOZOLPYRIDINAMINES, A PROCEDURE FOR THE PREPARATION AND USE THEREOF AS MEDICINES.
EE200000207A (en) 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use
DK392288A (en) HUMAN MONOCLONAL ANTIBODIES AND PROPHYLACTIC AND THERAPEUTIC AGENTS AGAINST INFRECTIOUS DISEASES CONTAINING THE SAME AS ACTIVE INGREDIENT
NO971879D0 (en) Preparation for transdermal administration
AU1494788A (en) Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
NO982549D0 (en) 5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic use thereof